Posted by AGORACOM
at 1:27 PM on Friday, April 3rd, 2020
RECENT HIGHLIGHTS
Immune Support Product Line Launched on March 14, 2020 Acquired over 5,500 new customers seeking natural solutions to help support their family’s immune systems, yielding an average initial order value of $189.00 USD.
First Class CBD brand achieved sales of Cdn$2,981,000 February 2020
Marketing efforts improved gross margins by 4.9% from January 2020 to February 2020.
February 2020 revenue represents an increase of 832% over the same period last year.
Plans to continue growth of First Class in the United States over the balance of 2020, as well as an expansion into the European market.
Formalized Joint Venture With Bevcanna Enterprises: Read More
Will share equal ownership in the Joint Venture and will be jointly responsible for developing and funding its operations
Company will provide manufacturing, marketing and distribution infrastructure in the European market.
Parties have determined an initial product launch and will provide further details on specific regions and timing once finalized
Formalized Collaboration for Sativida US Expansion Read MoreÂ
Acquired the intellectual property and trade names of Sativida
Unified Funding will provide assistance to Sativida with product sourcing, packaging, shipping, payment infrastructure and marketing
Sativida has become the number one search-ranked online retailer of CBD products in Spain and Mexico
Entered into Licensing Agreement with Phenome One Read More
A privately held full-service live genetic and seed preservation cannabis company.
Mota will have full access to Canada’s largest live genetic cannabis library with over 350 cultivars
Mota will have the right to propagate, cultivate, harvest and process a minimum of 10 selected cultivars
2 World Class Brands:
#1. FIRST CLASS CBD: ONE OF THE LARGEST US BASED ONLINE RETAILERS OF CBD PRODUCTS
HIGHLIGHTS:
Leader in online CBD sales in North America
Crop to package model: US grown CBD hemp
Acquired at a 1.5 times revenue valuation
Current customer base 142,000 customers -with additional leads of over 424,000 potential new customers
2019 Sales of $19.2M USD/ EBITDA of 2.7M USD
#2. SATIVIDA: ONLINE DIRECT TO CONSUMER RETAILER OF A VAST RANGE OF ORGANICE CBD OILS AND COSMETICS
HIGHLIGHTS:
Current distributor of CBD products in Spain, Portugal, Austria, Germany, France and the United Kingdom
Number one search-ranked online retailer in Spain and Mexico
Award winning product line known for its minimal heavy metal content and accurate CBD levels
100% organic products
About Mota Ventures Corp.
Mota Ventures is seeking to become a vertically integrated global CBD brand. Its plan is to cultivate and extract CBD into high-quality value added products from its Latin American operations and distribute it both domestically and internationally. Mota has established distribution networks through the acquisition of First Class CBD in the United States and Sativida in Europe. Mota Ventures is also seeking to acquire revenue producing CBD brands and operations in both Europe and North America, with the goal of establishing an international distribution network for CBD products. Low cost production, coupled with international, direct to customer, sales channels will provide the foundation for the success of Mota Ventures.
Posted by AGORACOM-JC
at 7:21 AM on Wednesday, April 1st, 2020
Announced that patient visits in corporate clinics increased by 593%% in March 2020 versus the same period in 2019,
total patient visits of 2,160 in March 2020 compared to 364 in March 2019
1Q 2020 patient visits increased by 478% versus the same period 2019, with total patient visits of 5,717 in 1Q 2020 compared to 1,196 in 1Q 2019.
VANCOUVER, BC / April 1, 2020 / EMPOWER CLINICS INC. (CSE: CBDT) (OTC: EPWCF) (Frankfurt 8EC) (“Empower” or the “Company”), a vertically integrated and growth-oriented life sciences company, is pleased to announce that patient visits in corporate clinics increased by 593%% in March 2020 versus the same period in 2019, with total patient visits of 2,160 in March 2020 compared to 364 in March 2019.
1Q 2020 patient visits increased by 478% versus the same period 2019, with total patient visits of 5,717 in 1Q 2020 compared to 1,196 in 1Q 2019.
“These are unprecedented times, yet our team members remain dedicated to supporting patients every day, at record levels, using new operational techniques and safety protocols” said Steven McAuley, Chairman & CEO of Empower. “I am so proud of our management, our staff’s willingness to adjust to changing times, and our commitment to the daily needs of patients.”
The Company has also entered into to a new tele-medicine service agreement that will provide access to our physicians across multiple states, offering current and new modalities to existing and new patients. Additional announcements about the Company’s digital health initiatives will be forthcoming.
The Company has also issued a total of 600,000 stock options priced at $0.05 CAD to investor relation service providers and to a Director of the Company.
ABOUT EMPOWER
Empower is a vertically-integrated health & wellness brand with it’s first hemp-derived CBD extraction facility under development, the Company produces its proprietary line of cannabidiol (CBD) based products and distributes products through company owned and franchised clinics, with wholesale partnerships, online channels and with new retail opportunities nationwide in the U.S. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies.
For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.
Posted by AGORACOM-JC
at 9:39 AM on Tuesday, March 31st, 2020
Signed a letter of intent with Heather Marianna, LLC parent company of (“Beauty Kitchenâ€)
The Board of Directors of Primo have approved, in principle, a proposal to acquire and raise funding in respect of its interests in the “Beauty Kitchen” projects into a newly incorporated subsidiary
Beauty Kitchen is a company that manufactures fresh handmade beauty care, personal care, and cosmetics products, which was born from the hugely popular Beauty Kitchen YouTube series
VANCOUVER, British Columbia, March 31, 2020 – PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) is pleased to announce that it has signed a letter of intent (“LOIâ€) with Heather Marianna, LLC parent company of (“Beauty Kitchenâ€) a Nevada company. The Board of Directors of Primo have approved, in principle, a proposal to acquire and raise funding in respect of its interests in the “Beauty Kitchen” projects into a newly incorporated subsidiary.
Beauty Kitchen proposes a transaction whereby its management team
(and affiliates) incorporates a Canadian corporation, tentatively called
“Marianna, Inc.†to receive exclusive Canadian distribution rights to
its CBD infused and non-CBD infused products in handmade beauty care,
personal care, and cosmetic products. Primo will acquire ownership
interest of a minimum of 25% in the newly incorporated subsidiary.
Beauty Kitchen is a company that manufactures fresh handmade beauty
care, personal care, and cosmetics products, which was born from the
hugely popular Beauty Kitchen YouTube series. Founder and CEO, Heather
Marianna, skyrocketed in popularity with the launch of her Beauty
Kitchen YouTube series in 2012 where she showcased simple,
do-it-yourself beauty recipes made with common kitchen household
ingredients. The series generated a powerful following of more than 4
million viewers.
The Company plans to reorganize its operating divisions along with
the closing of the acquisition and financing for its subsidiary. It is
proposed that the transaction may be carried within a statutory plan of
arrangement (the “Spin-Out“) pursuant to the Business Corporations Act (British Columbia) under the “reorganization exemption†under the Securities Act.
The Plan of Arrangement will be subject to the approval of Primo’s
shareholders which Primo intends to seek at a special meeting of
shareholders (the “Shareholders’ Meeting“). The date
for the Shareholders Meeting has not yet been determined. The
transaction may be subject to rules of The Canadian Stock Exchange (“CSE“) approval and any Plan of Arrangement requires approval by Court Order of the British Columbia Supreme Court.
The Parties intend to draft and execute a definitive agreement (the “Definitive Agreementâ€)
with detailed terms as soon as practicable, and complete this
Transaction on or before April 30, 2020. Terms of the LOI are subject to
change as set out in the Definitive Agreement.
Andy Jagpal, President Comments:
“This LOI is our second step into the growing CBD and Natural
Health market. Primo’s vision and strategy is to acquire a minority
interest in companies like Beauty Kitchen and Thrive as our growth
strategy in 2020 and beyond. These two brands along with Primo’s will
enter this fledgling Natural Health & CBD market with an online
presence as well as retail one too. We are very excited about the value
this partnership will bring to the company and its shareholders.â€
About Beauty Kitchen Beauty Kitchen is a company
that manufactures fresh handmade beauty care, personal care, and
cosmetics products, which was born from the hugely popular Beauty Kitchen YouTube series.
The founder, Heather Marianna, a bubbly social media personality,
translated her passion for looking and feeling her absolute best into
the development of her all-natural beauty and skincare product line.
Beauty Kitchen’s founder and CEO, Heather Marianna, skyrocketed in
popularity with the launch of her Beauty Kitchen YouTube series in 2012
where she showcased simple, do-it-yourself beauty recipes made with
common kitchen household ingredients. The series generated a powerful
following of more than 4 million viewers. Beauty Kitchen is regularly featured in: Forbes,
The Source, MTV, Bravo, The New York Post, People, Flipsnack, Vegas,
Star Magazine, Radar Online and many more media outlets with a large
following of celebrities who use their products which include; Sean
“Puffy†Combs, Christina Milian, David Arquette, George Lopez, Larissa
Lima, Shark Tank’s Barbara Corcoran, Candace Cameron, Jen Harley, Lou
Ferrigno, The Real Housewives of Beverly Hills and others. For more information visit: www.beautykitchenonline.com
About Primo Nutraceuticals Primo Nutraceuticals
Inc. (“Primo” or the “Company”) provides strategic capital to the
thriving cannabis cultivation sector through ownership and development
of commercial real estate and farm friendly properties. Primo is
dedicated to funding the rapid growth in production, processing, retail
and branding of cannabis and cannabis related products in Canada and the
United States. Primo has invested in several brands and is pursuing
partnerships with retailers and distribution companies in Canada and the
United States. Primo’s management is in the process of building a
corporate road map to further vertically integrate the Company,
specifically by way of “Primo†branded retail outlets – offering
“Thrive,” “Primo,” and a selection of curated partner brands. The
Company possesses proprietary formulas for cannabis edibles, topical,
and tinctures. Primo is focused on building a strong presence in the
hemp industry with the objective of extracting and selling cannabinoids
(CBD) products in both Canada and the United States.
On behalf of the Board of Directors
PRIMO NUTRACEUTICALS INC.
“Andy Jagpalâ€
President and Director
For further information, please contact Zoltan, IR Representative at: 604-722-0305, or; [email protected].
To learn more about what this news means to the shareholders visit
FORWARD LOOKING STATEMENTS: This news release
contains certain forward-looking statements within the meaning of
Canadian securities laws. Forward-looking statements are based on the
expectations and opinions of the Company’s management on the date the
statements are made. The assumptions used in the preparation of such
statements, although considered reasonable at the time of preparation,
may prove to be imprecise and, as such, undue reliance should not be
placed on forward-looking statements. The Company expressly disclaims
any intention or obligation to update or revise any forward-looking
statements whether as a result of new information, future events or
otherwise.
No regulatory authority has approved or disapproved the information contained in this news release.
Tags: CBD, covid19, Hemp, Marijuana, stocks Posted in PRIMO Nutraceuticals Inc. | Comments Off on Primo Nutraceuticals Inc. $PRMO.ca Signs LOI to enter in to Funding and Share Purchase Agreement for 25% with Beauty Kitchen (Canada) $CROP.ca $VP.ca NF.ca $MCOA
Posted by AGORACOM-JC
at 9:21 AM on Monday, March 30th, 2020
At a time when established Cannabis stocks are struggling due to an inability to actually deliver real businesses, Hollister Biosciences (HOLL:CSE) has been quietly building a real business, products, revenue and customers in 220 of California’s 600 dispensaries …. and growing, including California’s #1 hash infused pre-roll “Hashbone”. Â
If that was all Hollister had going, they’d be in great shape with a super bright future and better than most Cannabis companies (small and large) who can’t even get product out the door. Â
BUT THERE’S MORE – THE $20,000,000 ACQUISITION THAT COMES WITH $CDN 16.4M REVENUE & $CDN 2.48M EBITDA Â
Hollister has closed their purchase of Venom Extracts, one of Arizona’s largest producers of Award-Winning Medical Cannabis Distillate. Just how good is Venom? In 2019, Venom generated $CDN 16.4M in revenue and $CDN 2.48M EBITDA in 2019 … and all of that was just from the state of Arizona. Â
In this amazing interview, Venom Founder Jake Cohen discusses Venom’s aggressive plans to expand its brand and success into other states, including California as it benefits from Hollister’s distribution into 220 dispensaries. Right now, some of you may be thinking, “yeah but everybody thinks they are going to expand” …. but Jake’s words, as well as those of Alex Somjen (President) and Carl Saling (CEO) are backed up by action.  Â
Specifically, a significant chunk of Venom’s acquisition shares kicks in if/when revenues hit $CDN 30,000 and $CDN 40,000 …. by December 31, 2021. In my experience, companies joining forces don’t include such terms if there isn’t a reasonable expectation for hitting those numbers. It doesn’t guarantee it but you can bet they have good reason to believe Venom sales will get to one or both of those numbers in just 21 months from now. Â
If you’re looking for Cannabis companies that are going to survive and thrive over this next decade, then grab your favourite beverage and watch this great interview with Carl Saling, Alex Somjen and Jacob Cohen.
Posted by AGORACOM-JC
at 7:18 AM on Monday, March 30th, 2020
This highly accretive acquisition strengthens Hollister’s brand portfolio and broadens its distribution footprint across multiple states positioning Hollister to transform into an industry leader in 2020 and beyond
Venom Extracts reports having generated over CDN$16.4 million in revenue and over CDN$2.5 million in EBITDA from its product line of cannabis concentrates and cartridges.Â
VANCOUVER, March 30, 2020Â –Hollister Biosciences Inc.(CSE: HOLL, FRANKFURT: HOB, OTC: HSTRF) (the “Company” or “Hollister“), a diversified cannabis branding company with products in 220 dispensaries throughout California, is pleased to announce that further to the signing of the definitive agreement, as amended (the “SEA“), the Company has now closed its transformational acquisition of Venom Extracts (“Venom Extracts“), a leading Arizona cannabis extract brand and one of the state’s largest producers of award-winning medical cannabis distillate and related products (the “Transaction“).
HIGHLY ACCRETIVE $20,000,000 ACQUISITION, ADDING OVER CDN$16.4 MILLION OF 2019 REVENUE
For the year ended December 31, 2019, management of Venom Extracts reports having generated over CDN$16.4 million in revenue and over CDN$2.5 million
in EBITDA from its product line of cannabis concentrates and
cartridges. Venom Extract’s management also reports a strong start to
2020 and is anticipating record Q1 revenue.
The all-stock purchase price of approximately CDN$20,000,000
represents a transaction multiple of 1.2x 2019 revenue, with
approximately 70% of the consideration paid upfront and the
approximately 30% balance to be paid upon milestone achievements related
to revenue targets for Venom Extracts, or in any event, on December 31, 2021. After conducting normal course due diligence, the Transaction closed effective March 24, 2020 (the “Closing Date“).
KEY TERMS OF THE TRANSACTION:
Pursuant to the terms of the SEA, the Company has acquired Venom Extracts for consideration of CDN$20,000,145.20 which is to be satisfied by the issuance of 70,390,672 Hollister common shares (the “Payment Shares“) on the Closing Date pro rata to the shareholders of Venom Extracts and an additional 29,610,054 common shares (the “Earn-Out Shares“)
to certain former shareholders of Venom Extracts on the earlier of (i)
Venom Extracts reaching certain revenue milestones (detailed below), or
(ii) December 31, 2021.
The Payment Shares and the Earn-Out Shares will be issued at a deemed value of CDN$0.20 per share;
The Payment Shares are subject to certain voluntary hold periods
with 90% of the Payment Shares being subject to hold periods as follows:
15% until May 25, 2020; and an additional 15% every six months until November 25, 2022;
The Earn-Out Shares will be issued on the earlier of (i) December 31, 2021, or (ii) when and if the following milestones have been met:
19,740,036 Earn-Out Shares will be issued when revenue of Venom Extracts reaches CDN$30,000,000 (calculated in accordance with IFRS from January 1, 2020); and
An additional 9,870,018 Earn-Out Shares will be issued when revenue of Venom Extracts reaches CDN$40,000,000 (calculated in accordance with IFRS from January 1, 2020).
“We are extremely pleased to complete this transformational and highly accretive acquisition”, shared Carl Saling, Founder and CEO of Hollister Biosciences Inc. “Our acquisition of Venom Extracts bolts on substantial revenue and EBITDA to Hollister, while providing Venom Extracts the ability to expand its offering of premium branded product into the California marketplace. Likewise, our acquisition also allows Hollister to introduce its products into the Arizona and Nevada marketplaces through Venom Extracts’ existing distribution channels.”
“This is an exciting acquisition and we are very pleased to announce closing”, shared Jacob Cohen, Founder of Venom Extracts. “This transaction represents the next step in ensuring the future growth of both Hollister and Venom Extracts. We are looking forward to increasing our geographic presence by expanding into the California marketplace through Hollister’s existing platform, and exploring expansion of our existing product portfolio collectively.”
In association with the acquisition, Hollister will not
be assuming any long-term debt, a new control position will be created
and there is no change in management, or the board of directors of Hollister being contemplated at this time.
In connection with the Transaction, the Company issued 6,000,000 common shares (the “Finder Shares“) to an arm’s length third party finder at a deemed price of $0.20
per Finder Share. The Finder Shares are subject to a statutory hold
period of four months and a day from the Closing Date which expires July 25, 2020.
This press release is available on the Company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.
None of the securities to be issued pursuant to the Transaction have
been or will be registered under the U.S. Securities Act of 1933, as
amended (the “U.S. Securities Act“), or any state
securities laws, and any securities issued pursuant to the Transaction
are anticipated to be issued in reliance upon available exemptions from
such registration requirements pursuant to Rule 506(b) of Regulation D
and/or Section 4(a)(2) of the U.S. Securities Act and applicable
exemptions under state securities laws. In addition, the securities
issued under an exemption from the registration requirements of the U.S.
Securities Act will be “restricted securities” as defined under Rule
144(a)(3) of the U.S. Securities Act and will contain the appropriate
restrictive legend as required under the U.S. Securities Act.
About Hollister Biosciences Inc.
Hollister Biosciences Inc. is a diversified cannabis company with
multiple, high-quality products now carried in 220 of Indus Holdings
(CSE: INDS), Hollister’s exclusive
distribution partner’s 600 dispensaries. This level of penetration is
expected to grow as the Company accelerates its seed to shelf, high
margin business and product development model.
Capitalizing on this success, Hollister’s vision is to
become the sought-after premium brand portfolio of innovative, high
quality cannabis across multiple states and hemp products nationwide.
Our wholly owned California subsidiary, Hollister Cannabis Co, is the 1st state and locally licensed Cannabis Company in the City of Hollister, California,
the birthplace of the “American Biker” from which we embrace the outlaw
roots of Hollister to drive our Company fearlessly down the road of
success.
Products from Hollister Cannabis Co. include HashBone, the brand’s
premier artisanal hash-infused pre-roll ranked as California’s #1 hash
infused pre-roll, along with solvent-free bubble hash, pre-packaged
flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD
pet tinctures.
Venom Extracts is one of Arizona’s premier extract
brands and one of the state’s largest producers of award-winning medical
cannabis distillate and related products. With an experienced
management team and unparalleled reputation for quality, Venom Extracts
prides itself as a differentiated extraction company by producing legal
Marijuana products at a price point that allows retailers to generate
higher profits. Focused on proprietary efficiencies, the Company is
able to produce more product per square foot than its competition,
maintaining lower costs and risks than a typical extraction company. The
company’s expansion strategy is centered on entering new markets/states
that are approved for medical cannabis use and/or approved or have a
reasonable expectation to be approved for recreational use in the near
future.
The CSE does not accept responsibility for the adequacy or accuracy of this release.
Forward-Looking Information: This news release includes certain
statements that may be deemed “forward-looking statements”. The use of
any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”,
“will”, “would”, “project”, “should”, “believe” and similar expressions
are intended to identify forward-looking statements. Although the
Company believes that the expectations and assumptions on which the
forward-looking statements are based are reasonable, undue reliance
should not be placed on the forward-looking statements because the
Company can give no assurance that they will prove to be correct. Since
forward-looking statements address future events and conditions, by
their very nature they involve inherent risks and uncertainties. These
statements speak only as of the date of this News Release. Actual
results could differ materially from those currently anticipated due to a
number of factors and risks including various risk factors discussed in
the Company’s disclosure documents which can be found under the
Company’s profile on www.sedar.com.
Tags: Cannabis, CBD, CSE, Hemp, Marijuana, stocks, tactical relief, tsx Posted in Featured, Hollister Biosciences | Comments Off on Hollister Biosciences $HOLL.ca Closes Transformational Acquisition of Rapidly Growing Venom Extracts Adding Over $16.4 Million In 2019 Revenue and $2.5 Million in EBITDA $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca
Posted by AGORACOM
at 5:06 PM on Friday, March 27th, 2020
Since March 14, 2020, Mota has acquired over 5,500 new customers
The product has yielded an average initial order value of $189.00 USD.
Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ:GR)(OTCPINK:PEMTF) (the “Company” or “Mota“) is pleased to announce that since the launch of its Immune Support product line on March 14, 2020, the Company has acquired over 5,500 new customers seeking natural solutions to help support their family’s immune systems. The popularity of the primary product has yielded an average initial order value for immune support customers of $189.00 USD. Earlier this week the Company introduced an Immune CBD oil and Elderberry Gummies. The new Immune CBD product contains CBD, B3, B12, vitamin C and zinc and is made from 100% pure essential oils containing cinnamon leaf, lemon, clove bud, lime, eucalyptus, globulus, rosemary, peppermint, spearmint and oregano.
The Company has acquired over
50,000 new customer inquiries for Immune Support/CBD products since
March 14, 2020. The Immune Support line is gaining interest from
customers that historically were hesitant to purchase CBD, but are now
interested in the Immune products and the potential anti-inflammatory
benefits of CBD. In addition, traditional brick-and-mortar stores have
been affected due to social distancing requirements, driving consumers
to purchase online from the safety of their homes.
“The Immune
Support product launch has been the most successful product launch in
the history of our First Class brand. E-Commerce is a fast-moving
sector, especially during these very unique times we are facing today.
Our ability as a company to quickly develop and launch new products to
meet market demand is a testament to our expertise. I am very excited by
the reception we have received to date for our Immune Line of products.
I project demand for the line will continue through Q2 and be a
significant driver to our growth for 2020,” stated Ryan Hoggan, CEO of
the Company.
Additionally, the Company has entered into a 12 month
programmatic digital advertising campaign with Native Ads, Inc. for a
total cost of C$80,000; consisting of C$72,000 for digital advertising,
paid distribution, and media buying over the campaign period and,
C$8,000 for content creation, consulting, managed services and
management fees over the course of the campaign period. Native Ads is a
full-service advertising agency, that owns and operates a proprietary ad
exchange with over 80 integrated SSPs (supply side platforms) resulting
in access to 3-7 billion daily North American ad impressions. Neither
Native Ads nor any of its directors and officers own any securities of
the Company.
About Mota Ventures Corp.
Mota is
seeking to become a vertically integrated global CBD brand. Its plan is
to cultivate and extract CBD into high-quality value-added products from
its Latin American operations and distribute it both domestically and
internationally. Its existing operations in Colombia consist of a
2.5-hectare site that has optimal year-round growing conditions and
access to all necessary infrastructure. Mota is looking to establish
sales channels and a distribution network internationally through the
acquisition of the Sativida and First Class CBD brands. Low cost
production, coupled with international, direct to customer sales
channels will provide the foundation for the success of Mota.
ON BEHALF OF THE BOARD OF DIRECTORS MOTA VENTURES CORP.
Ryan Hoggan Chief Executive Officer
For
further information, readers are encouraged to contact the President of
the Company, Joel Shacker, at +604.423.4733 or by email at [email protected] or www.motaventuresco.com
Posted by AGORACOM-JC
at 9:31 AM on Thursday, March 26th, 2020
SPONSOR: NORTHBUD (NBUD:CSE)
Sustainable low cost, high quality cannabinoid production and
procurement focusing on both bio-pharmaceutical development and
Cannabinoid Infused Products. The company recently received Canadian
Cultivation Licence for its Quebec Facility. Learn More.
Posted by AGORACOM
at 8:51 AM on Thursday, March 26th, 2020
Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ:GR)(OTCPINK:PEMTF) (the “Company” or “Mota“)
is pleased to announce that further to its January 10, 2020 news
release, it has now acquired the intellectual property and trade names
of Sativida from Sativida OU (Estonia). The Company will license both
back to Sativida OU’s subsidiary, VIDA BCN LABS S.L. (collectively with
Sativida OU, “Sativida“) in exchange for a royalty associated with the gross revenues generated by Sativida.
Sativida is an arms’-length producer and online retailer of cannabidiol (“CBD“)
and branded CBD products in various jurisdictions in Europe, including
Spain, Portugal, Austria, Germany, France and the United Kingdom.
Sativida currently develops and retails a vast range of organic CBD oils
and cosmetics across Europe and is in the process of expanding its
distribution network internationally to include the United States.
Sativida has become the number one search-ranked online retailer of CBD
products in Spain and Mexico, and intends to continue its expansion into
other countries in Europe and Latin America.
Through Mota, Sativida has an agreement with Unified Funding, LLC (“Unified“)
for the expansion of the brand into the United States. Unified will
provide assistance to Sativida with product sourcing, packaging,
shipping, payment infrastructure and marketing in the United States.
Unified Funding is an e-Commerce and technology company focused on
serving U.S.-based and international consumers in the CBD and natural
health products market. Powered by its proprietary technology platform,
Unified has created an e-Commerce ecosystem to scale its brands through
data analysis, strategic customer acquisition and supply chain
management. Since June 2015, Unified has generated a database of over
4.5 million consumers and has facilitated over US$200 million in
consumer transactions from more than one million paying customers.
“I
am very excited to announce the acquisition of the Sativida brand. This
gives Mota immediate entry into the European market and will be a
building block for our planned European expansion. Mota’s U.S.
operation, First Class CBD, is set to enter the European market and we
expect the acquisition of the Sativida brand to expedite this expansion.
Furthermore, our partnership with Unified Funding, LLC, the e-Commerce
platform behind the success of First Class CBD, will allow us to bring
the Sativida brand to the U.S. market as well,” stated Ryan Hoggan, CEO
of the Company.
Noah
Laith, founder of Sativida, commented, “Joining Mota is a major step
for Sativida that will provide access to the capital, connections and
infrastructure necessary to grow our business in Europe and
internationally.”
Pursuant to the previously announced binding agreement with Sativida dated January 9, 2020 (the “Transaction Agreement“), the Company was granted the right to acquire Sativida in stages (the “Transaction“),
at the discretion of the Company, as certain corporate and intellectual
property registrations were completed. To accomplish this, the Company
set up a wholly-owned Spanish subsidiary (“Spanish Subco“)
and coordinated the registration of various intellectual property and
trade names associated with business operations of Sativida.
The
Company, through Spanish Subco, has now completed the acquisition of
the intellectual property and trade names of Sativida in Spain, and will
license both back to Sativida in exchange for a royalty associated with
the gross revenues generated by Sativida. Pursuant to the Transaction
Agreement, the Company also holds the right to acquire, through Spanish
Subco, all of the outstanding share capital of Sativida at any time for
no additional consideration.
Consideration for the Transaction is made up of an initial component of €2,000,001 (the “Consideration“) and an earn-out component made up of three milestone payments based upon the revenue of Sativida (each, a “Milestone Payment“). The Consideration was paid in 5,496,221 common shares of the Company (the “Consideration Shares“)
at a deemed price of $0.5689 per share. Each Milestone Payment will be
based on a 400% multiple of Sativida’s revenue until the aggregate of
the Initial Consideration and Milestone Payments reaches €4,000,000, at
which point the multiple will be reduced to 100%. In no event will the
combined Milestone Payments and the value of the Initial Consideration
exceed €15,000,000. Payment of the Milestone Payments will be satisfied
by the Company issuing common shares (“Milestone Shares“)
to Sativida. The total number of Milestone Shares issuable to Sativida
will be determined by dividing the amount due by the volume weighted
average closing price of the Company’s common shares on the Canadian
Securities Exchange in the ten trading days prior to the day that the
Milestone Payment is due.
The
Consideration Shares and the Milestone Shares will each be subject to a
36-month pooling arrangement such that 10% of the Consideration Shares,
or the Milestone Shares, as applicable, will be released from escrow on
upon their issuance, with an additional 15% being released every
six-months thereafter until all Consideration Shares or all Milestone
Shares, as applicable, are released.
As
part of the Transaction, Mota Ventures will enter into employment
contracts with certain employees of Sativida and will provide an option
pool that may be divided among the employees of Sativida equal to
€60,000 in stock options of Mota Ventures for every €1,000,000 in
revenue that Sativida earns, subject to certain conditions.
Additionally, Mota Ventures has paid a 10% finder’s fee based on the
total value of the Consideration Shares (528,072 common shares) to
certain finders that assisted in introducing the Transaction to the
parties as well as a 2% administrative success fee based on the total
value of the Consideration Shares (105,614 common shares) to a
consultant who assisted in the administration of the transaction.
The
Company and Sativida are at arms’-length. The Transaction is not
expected to result in a “reverse-takeover” or “fundamental change” for
the Company under the policies of the Canadian Securities Exchange, or
result in the creation of any new insider or control person of the
Company. No changes to the board of directors, or management, of the
Company are contemplated in connection with the Transaction.
About Mota Ventures Corp.
Mota
is seeking to become a vertically integrated global CBD brand. Its plan
is to cultivate and extract CBD into high-quality value-added products
from its Latin American operations and distribute it both domestically
and internationally. Its existing operations in Colombia consist of a
2.5-hectare site that has optimal year-round growing conditions and
access to all necessary infrastructure. Mota is looking to establish
sales channels and a distribution network internationally through the
acquisition of the Sativida and First Class CBD brands. Low cost
production, coupled with international, direct to customer sales
channels will provide the foundation for the success of Mota.
About Sativida
Sativida
is a producer and online retailer of CBD and branded CBD products in
various jurisdictions in Europe, including Spain and the United Kingdom.
Sativida currently develops and retails a vast range of organic CBD
oils and cosmetics across Europe and is currently expanding its
distribution network internationally. For more information on Sativida,
readers are encouraged to review their website at www.sativida.es.
ON BEHALF OF THE BOARD OF DIRECTORS MOTA VENTURES CORP.
Ryan Hoggan Chief Executive Officer
For
further information, readers are encouraged to contact the President of
the Company, Joel Shacker, at +604.423.4733 or by email at [email protected] or www.motaventuresco.com
Posted by AGORACOM-JC
at 4:13 PM on Tuesday, March 24th, 2020
As the impact of COVID-19 is felt across the globe, and with the reported cases of the corona virus spreading rapidly across Canada and the US, Primo proudly introduced a line of hand sanitizers in collaboration with Beauty Kitchen to help mitigate the spread of germs.
The directors of Primo are passionate about wanting to help their
local communities fight the spread of germs by manufacturing the “Primo
Clean†hand sanitizer and giving it away for free.
Posted by AGORACOM-JC
at 9:37 AM on Tuesday, March 24th, 2020
Signed a production order with Celebrity Driven Brand Beauty Kitchen to provide a free non-hydroalcoholic gel to local communities after fears of hand sanitizer shortages.
VANCOUVER, British Columbia, March 24, 2020 — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”)Â is pleased to announce that it has signed a production order with Celebrity Driven Brand Beauty Kitchen to provide a free non-hydroalcoholic gel to local communities after fears of hand sanitizer shortages.
As the impact of COVID-19 is felt across the globe, and with the reported cases of the corona virus spreading rapidly across Canada and the US,
Primo Nutraceuticals feel it is our obligation, as corporate citizens,
to address every aspect of our operations with the goal of ensuring that
our workplace has proper business protocols in place for business to
continue; and that our business community, friends, family and the
public at large are safe guarded. We are proud to introduce a line of
hand sanitizers in collaboration with Beauty Kitchen to help mitigate
the spread of germs in our communities.
The directors of Primo are passionate about wanting to help their
local communities fight the spread of germs by manufacturing the “Primo
Clean†hand sanitizer and giving it away for free.
Andy Jagpal, President Comments:
“Through this initiative, Primo intends to help address the risk
of a lack of hand sanitizer products in our local communities which will
enable a greater number of people to continue to take the right action
to protect themselves from the spread of the germs.”
PRIMO’s move comes in the wake of widespread shortages of hand
sanitizer across the globe. In New York Gov. Andrew Cuomo announced that
the state would be employing inmates in order to produce its own hand sanitizer.
The CDC
recommends washing your hands with soap and water whenever possible as
it will significantly reduce the amount of all types of germs and
chemicals on hands. However, if soap and water are not available, using
hand sanitizer can help you avoid spreading germs to others. Please note
however, that hand sanitizers may not be as effective when hands are
visibly dirty or greasy.
About Beauty Kitchen
Beauty Kitchen is a company that manufactures fresh handmade beauty
care, personal care, and cosmetics products, which was born from the
hugely popular Beauty Kitchen YouTube series.
The founder, Heather Marianna, a bubbly social media personality,
translated her passion for looking and feeling her absolute best into
the development of her all-natural beauty and skincare product line.
Beauty Kitchen’s founder and CEO, Heather Marianna, skyrocketed in
popularity with the launch of her Beauty Kitchen YouTube series in 2012
where she showcased simple, do-it-yourself beauty recipes made with
common kitchen household ingredients. The series generated a powerful
following of more than 4 million viewers. Beauty Kitchen is regularly featured in: Forbes,
The Source, MTV, Bravo, The New York Post, People, Flipsnack, Vegas,
Star Magazine, Radar Online and many more media outlets with a large
following of celebrities who use their products which include; Sean
“Puffy†Combs, Christina Milian, David Arquette, George Lopez, Larissa
Lima, Shark Tank’s Barbara Corcoran, Candace Cameron, Jen Harley, Lou
Ferrigno, The Real Housewives of Beverly Hills and others. For more information visit:www.beautykitchenonline.com
About Primo Nutraceuticals
Primo Nutraceuticals Inc. (“Primo” or the “Company”) provides
strategic capital to the thriving cannabis cultivation sector through
ownership and development of commercial real estate and farm friendly
properties. Primo is dedicated to funding the rapid growth in
production, processing, retail and branding of cannabis and cannabis
related products in Canada and the United States. Primo provides fully
built out turnkey facilities equipped with state-of-the-art growing
infrastructure to cannabis growers and processors. In addition to the
Company’s flagship hemp project in Oregon State and the Greenhouse
campus in Washington State, Primo has invested in several brands and is
pursuing partnerships with retailers and distribution companies in
Canada and the United States. Primo’s management is in the process of
building a corporate road map to further vertically integrate the
Company, specifically by way of “Primo†branded retail outlets –
offering “Thrive,” “Primo,” and a selection of curated partner brands.
The Company possesses proprietary formulas for cannabis edibles,
topical, and tinctures. Primo is focused on building a strong presence
in the hemp industry with the objective of extracting and
selling cannabinoids (CBD) products in both Canada and the United
States.
On behalf of the Board of Directors
PRIMO NUTRACEUTICALS INC.
“Andy Jagpalâ€
President and Director
To learn more about what this news means to the shareholders visit https://marketnewsfirst.com/primo-nutraceuticals
For further information, please contact Zoltan, IR Representative at: 604-722-0305 [email protected].
FORWARD LOOKING STATEMENTS: This news release
contains certain forward-looking statements within the meaning of
Canadian securities laws. Forward-looking statements are based on the
expectations and opinions of the Company’s management on the date the
statements are made. The assumptions used in the preparation of such
statements, although considered reasonable at the time of preparation,
may prove to be imprecise and, as such, undue reliance should not be
placed on forward-looking statements. The Company expressly disclaims
any intention or obligation to update or revise any forward-looking
statements whether as a result of new information, future events or
otherwise.
No regulatory authority has approved or disapproved the information contained in this news release.
